Cargando…

Forty‐three key gene expressions involved in the effect of indoleamine 2,3‐dioxygenase 1 expression on cancer prognosis may be a potential indoleamine 2,3‐dioxygenase 1 inhibitor biomarker

Detalles Bibliográficos
Autores principales: Li, Weirui, Guo, Leilei, Xing, Zikang, Fang, Xin, Liang, Heng, Zhang, Shengnan, Shi, Lei, Kuang, Chunxiang, Shi, Leming, Zheng, Yuanting, Hu, Yueqing, Yang, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888544/
https://www.ncbi.nlm.nih.gov/pubmed/33634987
http://dx.doi.org/10.1002/ctm2.330
_version_ 1783652184809799680
author Li, Weirui
Guo, Leilei
Xing, Zikang
Fang, Xin
Liang, Heng
Zhang, Shengnan
Shi, Lei
Kuang, Chunxiang
Shi, Leming
Zheng, Yuanting
Hu, Yueqing
Yang, Qing
author_facet Li, Weirui
Guo, Leilei
Xing, Zikang
Fang, Xin
Liang, Heng
Zhang, Shengnan
Shi, Lei
Kuang, Chunxiang
Shi, Leming
Zheng, Yuanting
Hu, Yueqing
Yang, Qing
author_sort Li, Weirui
collection PubMed
description
format Online
Article
Text
id pubmed-7888544
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-78885442021-02-26 Forty‐three key gene expressions involved in the effect of indoleamine 2,3‐dioxygenase 1 expression on cancer prognosis may be a potential indoleamine 2,3‐dioxygenase 1 inhibitor biomarker Li, Weirui Guo, Leilei Xing, Zikang Fang, Xin Liang, Heng Zhang, Shengnan Shi, Lei Kuang, Chunxiang Shi, Leming Zheng, Yuanting Hu, Yueqing Yang, Qing Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2021-02-17 /pmc/articles/PMC7888544/ /pubmed/33634987 http://dx.doi.org/10.1002/ctm2.330 Text en © 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to Editor
Li, Weirui
Guo, Leilei
Xing, Zikang
Fang, Xin
Liang, Heng
Zhang, Shengnan
Shi, Lei
Kuang, Chunxiang
Shi, Leming
Zheng, Yuanting
Hu, Yueqing
Yang, Qing
Forty‐three key gene expressions involved in the effect of indoleamine 2,3‐dioxygenase 1 expression on cancer prognosis may be a potential indoleamine 2,3‐dioxygenase 1 inhibitor biomarker
title Forty‐three key gene expressions involved in the effect of indoleamine 2,3‐dioxygenase 1 expression on cancer prognosis may be a potential indoleamine 2,3‐dioxygenase 1 inhibitor biomarker
title_full Forty‐three key gene expressions involved in the effect of indoleamine 2,3‐dioxygenase 1 expression on cancer prognosis may be a potential indoleamine 2,3‐dioxygenase 1 inhibitor biomarker
title_fullStr Forty‐three key gene expressions involved in the effect of indoleamine 2,3‐dioxygenase 1 expression on cancer prognosis may be a potential indoleamine 2,3‐dioxygenase 1 inhibitor biomarker
title_full_unstemmed Forty‐three key gene expressions involved in the effect of indoleamine 2,3‐dioxygenase 1 expression on cancer prognosis may be a potential indoleamine 2,3‐dioxygenase 1 inhibitor biomarker
title_short Forty‐three key gene expressions involved in the effect of indoleamine 2,3‐dioxygenase 1 expression on cancer prognosis may be a potential indoleamine 2,3‐dioxygenase 1 inhibitor biomarker
title_sort forty‐three key gene expressions involved in the effect of indoleamine 2,3‐dioxygenase 1 expression on cancer prognosis may be a potential indoleamine 2,3‐dioxygenase 1 inhibitor biomarker
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888544/
https://www.ncbi.nlm.nih.gov/pubmed/33634987
http://dx.doi.org/10.1002/ctm2.330
work_keys_str_mv AT liweirui fortythreekeygeneexpressionsinvolvedintheeffectofindoleamine23dioxygenase1expressiononcancerprognosismaybeapotentialindoleamine23dioxygenase1inhibitorbiomarker
AT guoleilei fortythreekeygeneexpressionsinvolvedintheeffectofindoleamine23dioxygenase1expressiononcancerprognosismaybeapotentialindoleamine23dioxygenase1inhibitorbiomarker
AT xingzikang fortythreekeygeneexpressionsinvolvedintheeffectofindoleamine23dioxygenase1expressiononcancerprognosismaybeapotentialindoleamine23dioxygenase1inhibitorbiomarker
AT fangxin fortythreekeygeneexpressionsinvolvedintheeffectofindoleamine23dioxygenase1expressiononcancerprognosismaybeapotentialindoleamine23dioxygenase1inhibitorbiomarker
AT liangheng fortythreekeygeneexpressionsinvolvedintheeffectofindoleamine23dioxygenase1expressiononcancerprognosismaybeapotentialindoleamine23dioxygenase1inhibitorbiomarker
AT zhangshengnan fortythreekeygeneexpressionsinvolvedintheeffectofindoleamine23dioxygenase1expressiononcancerprognosismaybeapotentialindoleamine23dioxygenase1inhibitorbiomarker
AT shilei fortythreekeygeneexpressionsinvolvedintheeffectofindoleamine23dioxygenase1expressiononcancerprognosismaybeapotentialindoleamine23dioxygenase1inhibitorbiomarker
AT kuangchunxiang fortythreekeygeneexpressionsinvolvedintheeffectofindoleamine23dioxygenase1expressiononcancerprognosismaybeapotentialindoleamine23dioxygenase1inhibitorbiomarker
AT shileming fortythreekeygeneexpressionsinvolvedintheeffectofindoleamine23dioxygenase1expressiononcancerprognosismaybeapotentialindoleamine23dioxygenase1inhibitorbiomarker
AT zhengyuanting fortythreekeygeneexpressionsinvolvedintheeffectofindoleamine23dioxygenase1expressiononcancerprognosismaybeapotentialindoleamine23dioxygenase1inhibitorbiomarker
AT huyueqing fortythreekeygeneexpressionsinvolvedintheeffectofindoleamine23dioxygenase1expressiononcancerprognosismaybeapotentialindoleamine23dioxygenase1inhibitorbiomarker
AT yangqing fortythreekeygeneexpressionsinvolvedintheeffectofindoleamine23dioxygenase1expressiononcancerprognosismaybeapotentialindoleamine23dioxygenase1inhibitorbiomarker